+91-33-4600-9199  (India), +1-414-240-5010 (U.S.)
Oncology Next Generation Sequencing (NGS) Market is expected to witness 12.5% CAGR between 2021-2031 - Market Insights, Size, Share, Growth, Analysis, and Forecast
Published : March 2021

According to a new market research report published by sheer analytics and insights, “The Global Oncology Next Generation Sequencing (NGS) Market was valued at $320.2 Million in 2020. Growing at a high CAGR of more than 12.5% between 2021 and 2031, as per the latest market research report titled Oncology NGS Market - Industry analysis, size, share, growth, trends, and forecast, 2021-2031.

Simple NGS or Next-Generation Sequencing workflows, coupled with continued cost reductions in reagents and instruments, can be expected to increase this technology. In addition to this, there are other significant growth trends in the market, such as companion diagnostics, personalized medicine, data integration, and growing advancements in cloud computing. The efforts taken to develop the genomic database for the population of India is expected to drive market growth during the forecast period. The effort has been undertaken specially for the Indian population. However, in this regard, the CSIR or the Council of Scientific and Industrial Research launched IndiGen Genome Project to sequence the whole genomes of 1,008 Indians in April 2019.

However, in this current pandemic of COVID-19, the Oncology NGS Market is affected much. It changes the growth rate graph slightly in the Oncology NGS Market. But it has been expected that after the pandemic situation, the Oncology NGS Market will reach a high position in the graph. Apart from that, the Oncology NGS sector's rising across the region is anticipated to offer a massive opportunity for market growth in the next forecast period of 2021 to 2031.

Geographically, The Oncology NGS Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.   

The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include Illumina, Inc., Genotypic Technology Pvt. Ltd., Tecan Trading AG, SciGenom Labs Pvt. Ltd., Xcelris Labs Ltd., Eurofins Scientific, 4baseCare, MedGenome, Sayre Therapeutics, Redcliffe Lifesciences, Partek Incorporated, Bio-Rad Laboratories, Myriad Genetics, Hologic, Inc. (Gen-Probe Incorporated), and Horizon Discovery Group plc among others.

The Global Oncology Next Generation Sequencing (NGS) Market Has Been Segmented into:

Global Oncology Next Generation Sequencing (NGS) Market: By Technology

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted & Gene Panel Sequencing
    • Amplicon-based
    • Hybridization-based

Global Oncology Next Generation Sequencing (NGS) Market: By Application

  • Diagnostics and Screening
    • Screening
    • Sporadic Cancer
    • Inherited Cancer
    • Companion Diagnostics
  • Research Studies

Global Oncology Next Generation Sequencing (NGS) Market: By Product & Service

  • Platforms and Related Products
    • Panels
    • Consumables
    • Platforms
  • Services

Global Oncology Next Generation Sequencing (NGS) Market: By Workflow

  • Pre-Sequencing
    • NGS Library Preparation Kits
    • Semi-automated Library Preparation
    • Automated Library Preparation
    • Clonal Amplification
  • Sequencing
    • NGS Data Analysis
    • NGS Primary Data Analysis
    • NGS Secondary Data Analysis
    • NGS Tertiary Data Analysis

Global Oncology Next Generation Sequencing (NGS) Market: By End-Use

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other users

Global Oncology Next Generation Sequencing (NGS) Market: By Region

  • North America
    • USA
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, Middle East & Africa
    • Brazil
    • South Africa
    • UAE
    • Rest of LAMEA
Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links